Abstract
The clinical and angiographic predictors of coronary artery aneurysm (CAA) formation in patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) are not clear. This study aims to assess the predictors of CAA formation after primary PCI. 3,428 patients who underwent PCI for STEMI were enrolled. The average period of follow-up was mean 48 months (range 35–56 months) after PCI. During this time, 1,304 patients were underwent follow-up coronary angiography. CAA was detected in 21 patients (1.6 %). CAA occurred at the segment of stent implantation in all patients. The clinical and angiographic data were compared between patients with CAA group (n = 21) and without CAA group (n = 1,283). Patients who developed CAA had longer reperfusion time, higher high-sensitiviy C-reactive protein (hs-CRP) levels and neutrophil to lymphocyte ratio than those who had without CAA. Angiographically, CAA developed proximally located lesions and lesion length was significantly greater in patients with CAA than without CAA. Statin and beta-blocker discontinuation were found higher in stent-associated CAA. Every 1 mg/l increase in hs-CRP and implantation of drug eluting stent (DES) were independent predictor of CAA formation after STEMI. Baseline elevated inflammation status and DES implantation in the setting of STEMI may predict the CAA formation.
Similar content being viewed by others
References
Aoki J, Kirtane A, Leon MB, Dangas G (2008) Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv 1:14–21
Karabay CY, Kocabay G, Tasar O, Kalayci A, Guler A, Kirma C (2013) Evaluation of aneurysm after coronary stent implantation by optical coherence tomography. Kardiol Pol 71:659
Yoshikawa D, Ishii H, Aoyama Y, Ichimiya H, Shimizu Y, Isobe S et al (2010) Optical coherence tomography images of a coronary artery aneurysm in an infarct-related artery 6 months after bare-metal stent implantation. JACC Cardiovasc Interv 3:1300–1302
Bajaj S, Parikh R, Hamdan A, Bikkina M (2010) Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review. Tex Heart Inst J 37:449–544
Slota PA, Fischman DL, Savage MP, Rake R, Goldberg S (1997) Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. STRESS Trial Investigators. Am J Cardiol 79:1104–1106
Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701–705
Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC et al (2007) Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115:1051–1058
Ahn CM, Hong BK, Kim JY, Min PK, Yoon YW, Lee BK et al (2010) Incidence and natural history of coronary artery aneurysm developing after drug-eluting stent implantation. Am Heart J 160:987–994
Feng T, Yundai C, Hongbin L, Lian C, Zhijun S, Jun G et al (2013) Evaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography. Int J Cardiovasc Imaging 29:1677–1683
Alfonso F, Pérez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R et al (2009) Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol 53:2053–2060
Wang KY, Ting CT, St John Sutton M, Chen YT (1999) Coronary artery aneurysms: a 25-patient study. Catheter Cardiovasc Interv 48:31–38
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41
Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of Infarcting Myocardium Early II trial substudy. Circulation 102:2031–2037
Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555
Gibson CM, de Lemos JA, Murphy SA et al (2001) Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103:2550–2554
Yip HK, Chen MC, Chang HW et al (2002) Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow flow and no-reflow. Chest 122:1322–1332
Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879–888
Syed M, Lesch M (1997) Coronary artery aneurysm: a review. Prog Cardiovasc Dis 40:77–84
Slota PA, Fischman DL, Savage MP, Rake R, Goldberg S (1997) Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. STRESS Trial Investigators. Am J Cardiol 79:1104–1106
Levisay JP, Roth RM, Schatz RA (2008) Coronary artery aneurysm formation after drug-eluting stent implantation. Cardiovasc Revasc Med 9:284–287
Akin I, Kische S, Rehders TC, Schneider H, Turan GR, Kleinfeldt T et al (2011) Very late coronary aneurysm formation with subsequent stent thrombosis secondary to drug-eluting stent. Chin Med J (Engl) 124:3427–3429
Rab ST, King SB 3rd, Roubin GS, Carlin S, Hearn JA, Douglas JS Jr (1991) Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 18:1524–1528
Bavry AA, Chiu JH, Jefferson BK, Karha J, Bhatt DL, Ellis SG et al (2007) Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med 146:230–232
Virmani R, Kolodgie FD, Farb A (2004) Drug-eluting stents: are they really safe? Am Heart Hosp J 2:85–88
Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D et al (2005) Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294:1215–1223
Vassilev D, Hazan M, Dean L (2012) Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: first case report. Catheter Cardiovasc Interv 80:1223–1226
Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202
Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG et al (2005) Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46:1002–1005
Lee YS, Kim KS, Chang SG (2009) Three aneurysms developed in three different drug-eluting stents. Eur Heart J 30:1309
Ozden K, Sengül C, Fotbolcu H, Dindar I (2012) A late coronary aneurysm after sirolimus stent implantation which was treated with coronary graft stent]. Turk Kardiyol Dern Ars 40:440–443
Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A et al (2004) Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 147:42–48
Drakopoulou M, Toutouzas K, Stefanadi E, Tsiamis E, Tousoulis D, Stefanadis C (2009) Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis 206:335–339
Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL (2006) Usefulness of an elevated neutrophil -to-lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97:993–996
Wilson WR, Evans J, Bell PR, Thompson MM (2005) HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 30:259–262
Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S (2006) Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 97:279–280
Ozbay Y, Akbulut M, Balin M, Kayancicek H, Baydas, Korkmaz H (2007) The level of hs-CRP in coronary artery ectasia and its response to statin and an- giotensin-converting enzyme inhibitor treatment. Med Inflamm 2007:89649
Conflict of interest
No conflicts to disclosure
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karabay, C.Y., Kocabay, G., Guler, A. et al. Predictors of coronary artery aneurysm after stent implantation in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Int J Cardiovasc Imaging 30, 1435–1444 (2014). https://doi.org/10.1007/s10554-014-0503-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-014-0503-z